Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
62.3M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
2K
-
Shares change
-
-29.5M
-
Total reported value, excl. options
-
$720
-
Value change
-
-$10.8M
-
Number of sells
-
-60
-
Price
-
$0.36
Significant Holders of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV) as of Q3 2025
62 filings reported holding ELEV - Elevation Oncology, Inc. - Common stock, par value $0.0001 per share as of Q3 2025.
Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2K shares
of 62.3M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include OSAIC HOLDINGS, INC. (2K shares), NISA INVESTMENT ADVISORS, LLC (0 shares), EverSource Wealth Advisors, LLC (0 shares), Y-Intercept (Hong Kong) Ltd (0 shares), CITIGROUP INC (0 shares), BML Capital Management, LLC (0 shares), DELTEC ASSET MANAGEMENT LLC (0 shares), Archer Investment Corp (0 shares), Palumbo Wealth Management LLC (0 shares), and True Wealth Design, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.